[Inhibition of premature labour--anti-inflammatory agents in the prevention of premature birth (author's transl)].
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D005769:Gastrointestinal Motility; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007234:Infant, Premature; D007267:Injections; D009756:Nylidrin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011448:Prostaglandin Antagonists; D013610:Tachycardia / Q000139:chemically induced; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D011448:Prostaglandin Antagonists; D009756:Nylidrin; D014700:Verapamil; D001241:Aspirin
Hemmung vorzeitiger Wehen. Prostaglandinantagonisten bei drohender Frühgeburt.